The FDA has not approved a stem-cell or exosome therapy specifically for erectile dysfunction as a licensed product. Investigational MSC protocols are registered with the NIH but remain unapproved for this indication. The EMA likewise has not granted a marketed ED-specific stem-cell product. Phosphodiesterase-5 inhibitors (sildenafil, tadalafil, vardenafil) remain the FDA-approved first-line pharmacological treatment. Patients should distinguish investigational stem-cell protocols from unproven direct-to-consumer ED clinics, which proliferate globally and often lack regulatory oversight.
Erectile dysfunction (ED) arises from vascular insufficiency, endothelial dysfunction, smooth-muscle pathology, or neurogenic impairment — often clustering with metabolic syndrome, atherosclerosis, and diabetes. Stem-cell investigations focus on whether placental mesenchymal stem cells and exosome preparations can regenerate penile vasculature, restore endothelial nitric-oxide-dependent relaxation, and repair cavernous smooth-muscle tissue. With 35 registered trials and 5 currently recruiting, the biological rationale targets restoration of penile erectile mechanics through vascular and tissue regeneration. Early clinical data suggest potential for improving erectile function, increasing rigidity and tumescence duration, and potentially reducing pharmacological dependence on phosphodiesterase-5 inhibitors when stem-cell therapy complements standard medical management.
Sunt un candidat? → · Erectile Dysfunction: full overview → · Cost Disfuncție Erectilă → · Cost →
Revizuit medical de echipa editorială a StemCellAtlas cu Dr Dmytro Stoyanov (Urologist · 31+ yrs clinical practice) ale clinicii partenere Stem Plus (Sofia), în funcție de orientările ISSCR, FDA și EMA. Educational information, not medical advice; figures indicative.
Medicină regenerativă certificată GMP în inima UE — de la 3.000–8.000 €, o fracțiune din prețurile din SUA sau Germania. Protocoale personalizate pentru pacienți din peste 50 de țări.
Evaluare medicală gratuită